Ascertainment of acute liver injury in two European primary care databases

European Journal of Clinical Pharmacology

Volumn 70, Issue 10, 2014, Pages 1227-1235

  Ruigomez A ^a   Brauer, R ^b,e   Rodríguez, L A García ^a   Huerta, C ^c   Requena, G ^c   Gil, M ^c   De Abajo, Francisco ^c,d   Downey, G ^e   Bate, A ^f   Tepie, M Feudjo ^e   De Groot, M ^g   Schlienger, R ^h   Reynolds, R ⁱ   Klungel, O ^g  

^a Centro Español de Investigación Farmacoepidemiologica ^*  (Spain)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Division of Pharmacoepidemiology and Pharmacovigilance   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e Amgen NV   (United Kingdom)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^g UTRECHT UNIVERSITY   (Netherlands)

^h NOVARTIS PHARMA AG   (Switzerland)

ⁱ PFIZER INC   (United States)

Author keywords

Acute liver injury; BIFAP; Computer algorithms; CPRD; Diagnosis definition; Incidence; Primary care databases

Indexed keywords

ACUTE LUNG INJURY; ADOLESCENT; AGED; ALGORITHM; CHILD; DRUG-INDUCED LIVER INJURY; FACTUAL DATABASE; FEASIBILITY STUDY; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SPAIN; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ACUTE LUNG INJURY; ADOLESCENT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG-INDUCED LIVER INJURY; FEASIBILITY STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; SPAIN; YOUNG ADULT;

EID: 84929669965     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1721-y     Document Type: Article

References (32)

1. Trifiro G et al (2009) Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf 18:1176-1184
2. Lexchin J (2005) Drug withdrawals from the Canadian market for safety reasons, 1963-2004. CMAJ 172:765-767
3. Ibanez L, Perez E, Vidal X, Laporte JR (2002) Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 37:592-600
4. de Abajo FJ, Montero D, Madurga M, Garcia Rodriguez LA (2004) Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 58:71-80
5. El-Serag HB, Everhart JE (2002) Diabetes increases the risk of acute hepatic failure. Gastroenterology 122:1822-1828
6. Huerta C, Zhao SZ, Garcia Rodriguez LA (2002) Risk of acute liver injury in patients with diabetes. Pharmacotherapy 22:1091-1096
7. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ (1996) Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 156:1327-1332
8. Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH (1999) A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol 48:847-852
9. Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S (2013) Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 144:1419-1425
10. Platt R et al (2012) The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf 21(Suppl 1):1-8
11. Carnahan RM, Moores KG (2012) Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned. Pharmacoepidemiol Drug Saf 21(Suppl 1):82-89
12. Stang PE et al (2010) Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 153:600-606
13. Lo Re V 3rd (2013) Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf 22:861-872
14. Katz AJ, Ryan PB, Racoosin JA, Stang PE (2013) Assessment of case definitions for identifying acute liver injury in large observational databases. Drug Saf 36:651
15. Garcia Rodriguez LA, Perez Gutthann S (1998) Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45:419-425
16. Garcia Rodriguez LA, Perez-Gutthann S, Jick S (2000) In: Storm BL (ed) Pharmacoepidemiology, 3rd edn. Wiley, Ltd, Chichester, pp 375-385
17. Garcia Rodriguez LA, Ruigomez A (2010) Case validation in research using large databases. Br J Gen Pract 60:160-161
18. Abbing-Karahagopian V, Kurz X, de Vries F, van Staa TP, Alvarez Y, Hesse U, Hasford J, Dijk Lv, de Abajo FJ, Weil JG, Grimaldi-Bensouda L, Egberts AC, Reynolds RF, Klungel OH.(2014)Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol. 9(2):130 - 8
19. de Abajo FJ et al (2013) Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol 69:691-701
20. Chacon Garcia A, Ruigomez A, Garcia Rodriguez LA (2010) Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP. Aten Primaria 42:543-549
21. Connolly JP, McGavock H, Wilson-Davis K (1997) Research methodology: coding perceived morbidity in general practice - an evaluation of the Read Classification and the International Classification of Primary Care (ICPC). Pharmacoepidemiol Drug Saf 6:325-330
22. Benichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11:272-276
23. Garcia Rodriguez LA, Ruigomez A, Jick H (1997) A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy 17:721-728
24. Aithal GP et al (2011) Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89:806-815
25. Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H (1994) Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 154:311-316
26. Garcia Rodriguez LA, Perez Gutthann S, Walker AM, Lueck L (1992) The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ 305:865-868
27. Sgro C et al (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36:451-455
28. Graham DJ, Drinkard CR, Shatin D (2003) Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone. Am J Gastroenterol 98:175-179
29. de Lusignan S et al (2001) A survey to identify the clinical coding and classification systems currently in use across Europe. Stud Health Technol Inform 84:86-89
30. Ruigomez A, Martin-Merino E, Rodriguez LA (2010) Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 19:579-585
31. Goldberg DS, Lewis JD, Halpern SD, Weiner MG, Lo Re V 3rd (2013) Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiol Drug Saf 22:103-107
32. Salvador Rosa A, Moreno Perez JC, Sonego D, Garcia Rodriguez LA, de Abajo Iglesias FJ (2002) The BIFAP project: database for pharmaco-epidemiological research in primary care. Aten Primaria 30:655-661